UBS raised the firm’s price target on JFrog (FROG) to $38 from $30 and keeps a Buy rating on the shares after the company posted a “solid” Q3 report with billings growth of 37%, cRPO bookings acceleration to about 28% and total RPO growth of 47% reflecting larger deal momentum. Management’s tone was still cautious and the fiscal Q4 guidance didn’t significantly change despite the Q3 outperformance, but the firm continues to like JFrog’s opportunity to expand use cases in existing customers, the analyst tells investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio